RSS Search

News  Feeds  Tags  Search Shortcuts

FeedsFarm.com > FDA Approves BioGenex InSite(TM) HER-2/neu (CB11) Monoclonal AntibodyAntibody Aids in Breast Cancer Prognosis and Therapy Selection

Source:

mysan.de

Language:

Deutsch

Domain:

www.mysan.de

Search mysan.de:

FDA Approves BioGenex InSite(TM) HER-2/neu (CB11) Monoclonal AntibodyAntibody Aids in Breast Cancer Prognosis and Therapy Selection

4th Oct 2005, 15:54 GMT

View full story at www.mysan.de

FDA Approves BioGenex InSite(TM) HER-2/neu (CB11) Monoclonal AntibodyAntibody Aids in Breast Cancer Prognosis and Therapy Selection related news:

Latest news from mysan.de: